Triiodothyronine alongside levothyroxine in the management of hypothyroidism?

References

• Pirahanchi Y, Toro F, Jialal I. Physiology, thyroid stimulating hormone. StatPearls [Internet]; 2021 [cited 2021 Sep]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499850/.
   Google Scholar
• Hennessey JV. Pharmacodynamic and therapeutic actions of levothyroxine. In Kahaly GJ, editor. 70 Years of levothyroxine. Cham, Switzerland: Springer; 2021. pp. 23–45.
   Google Scholar
• Mariotti S, and, Beck-Peccoz P. Physiology of the hypothalamic-pituitary-thyroid axis. Endotext [Internet]; 2021 [cited 2021 Jul]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278958/.
   Google Scholar
• Lipp H-P. Administration and pharmacokinetics of levothyroxine. In Kahaly GJ, editor. 70 Years of levothyroxine. Cham, Switzerland: Springer; 2021. pp. 13–22.
   Google Scholar
• Colucci P, Yue CS, Ducharme M, et al. A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism. Eur Endocrinol. 2013;9(1):40–47.
   PubMedGoogle Scholar
• Luongo C, Dentice M, Salvatore D. Deiodinases and their intricate role in thyroid hormone homeostasis. Nat Rev Endocrinol. 2019;15(8):479–488.
   PubMed Web of Science ®Google Scholar
• Visser TJ. Cellular uptake of thyroid hormones. Endotext [Internet] [cited 2021 Jul]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK285565/.
   Google Scholar
• Werneck de Castro JP, Fonseca TL, Ueta CB, et al. Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine. J Clin Invest. 2015;125(2):769–781.
   PubMed Web of Science ®Google Scholar
• Sinha R, Yen PM. Cellular action of thyroid hormone. Endotext [Internet]; 2018 [cited 2021 Jul]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK285568/.
   Google Scholar
• Kahaly GJ. Therapeutic use of levothyroxine: a historical perspective. In Kahaly GJ, editor. 70 Years of levothyroxine. Cham, Switzerland: Springer; 2021. pp. 1–11.
   Google Scholar
• Prummel MF, Brokken LJ, Wiersinga WM. Ultra short-loop feedback control of thyrotropin secretion. Thyroid. 2004;14(10):825–829.
   PubMed Web of Science ®Google Scholar
• Razvi S, Bhana S, Mrabeti S. Challenges in interpreting thyroid stimulating hormone results in the diagnosis of thyroid dysfunction. J Thyroid Res. 2019;2019:4106816.
   PubMed Web of Science ®Google Scholar
• Sheehan MT. Biochemical testing of the thyroid: TSH is the best and, oftentimes, only test needed – a review for primary care. Clin Med Res. 2016;14(2):83–92.
   PubMed Web of Science ®Google Scholar
• Jonklaas J, ., Bianco AC, Bauer AJ, American Thyroid Association Task Force on Thyroid Hormone Replacement, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on thyroid hormone replacement. Thyroid. 2014;24(12):1670–1751.
   PubMed Web of Science ®Google Scholar
• Thyroid disease: assessment and management. NICE guideline [NG145]; November 2019 [cited 2020 May]. Available from: https://www.nice.org.uk/guidance/ng145/chapter/Recommendations.
   Google Scholar
• Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2(4):215–228.
   PubMedGoogle Scholar
• Rodriguez-Gutierrez R, Maraka S, Ospina NS, et al. Levothyroxine overuse: time for an about face? Lancet Diabetes Endocrinol. 2017;5(4):246–248.
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Davidson B, Bhagat S, et al. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. Jama. 2008;299(7):769–777.
   PubMed Web of Science ®Google Scholar
• Ito M, Miyauchi A, Hisakado M, et al. Biochemical markers reflecting thyroid function in athyreotic patients on levothyroxine monotherapy. Thyroid. 2017;27(4):484–490.
   PubMed Web of Science ®Google Scholar
• Gullo D, Latina A, Frasca F, et al. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One. 2011;6(8):e22552.
   PubMed Web of Science ®Google Scholar
• Fadeyev VV, Morgunova TB, Sytch JP, et al. TSH and thyroid hormones concentrations in patients with hypothyroidism receiving replacement therapy with L-thyroxine alone or in combination with L-triiodothyronine. Hormones (Athens). 2005;4:101–107.
   PubMedGoogle Scholar
• Wiersinga WM, Duntas L, Fadeyev V, et al. 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1(2):55–71.
   PubMedGoogle Scholar
• Razvi S, Mrabeti S, Luster M. Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review. Endocr Connect. 2020;9(11):R241–50.
   PubMed Web of Science ®Google Scholar
• Peterson SJ, Cappola AR, Castro MR, et al. An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid. 2018;28(6):707–721.
   PubMed Web of Science ®Google Scholar
• Centanni M, Benvenga S, Sachmechi I. Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report. J Endocrinol Invest. 2017;40(12):1289–1301.
   PubMed Web of Science ®Google Scholar
• Fitzgerald SP, Bean NG, Falhammar H, et al. Clinical parameters are more likely to be associated with thyroid hormone levels than with thyrotropin levels: a systematic review and meta-analysis. Thyroid. 2020;30(12):1695–1709.
   PubMed Web of Science ®Google Scholar
• Andersen S, Pedersen KM, Bruun NH, et al. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab. 2002;87(3):1068–1072.
   PubMed Web of Science ®Google Scholar
• Paragliola RM, Corsello A, Concolino P, et al. Iodothyronine deiodinases and reduced sensitivity to thyroid hormones. Front Biosci. 2020;25:201–228.
   Web of Science ®Google Scholar
• Razvi S, Jabbar A, Pingitore A, et al. Thyroid hormones and cardiovascular function and diseases. J Am Coll Cardiol. 2018;71(16):1781–1796.
   PubMed Web of Science ®Google Scholar
• Biondi B. The management of thyroid abnormalities in chronic heart failure. Heart Fail Clin. 2019;15(3):393–398.
   PubMed Web of Science ®Google Scholar
• Castagna MG, Dentice M, Cantara S, et al. DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients. J Clin Endocrinol Metab. 2017;102(5):1623–1630.
   PubMed Web of Science ®Google Scholar
• Citterio CE, Veluswamy B, Morgan SJ, et al. De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone. J Biol Chem. 2017;292(37):15434–15444.
   PubMed Web of Science ®Google Scholar
• Okosieme O, Gilbert J, Abraham P, et al. Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. Clin Endocrinol. 2016;84(6):799–808.
   PubMed Web of Science ®Google Scholar
• Saravanan P, Simmons DJ, Greenwood R, et al. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab. 2005;90(2):805–812.
   PubMed Web of Science ®Google Scholar
• Appelhof BC, Fliers E, Wekking EM, et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab. 2005;90(5):2666–2674.
   PubMed Web of Science ®Google Scholar
• Walsh JP, Shiels L, Lim EM, et al. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab. 2003;88(10):4543–4550.
   PubMed Web of Science ®Google Scholar
• Smith RN, Taylor SA, Massey JC. Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism. Br Med J. 1970;4(5728):145–148.
   PubMed Web of Science ®Google Scholar
• Valizadeh M, Seyyed-Majidi MR, Hajibeigloo H, et al. Efficacy of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary hypothyroidism: a randomized controlled trial. Endocr Res. 2009;34(3):80–89.
   PubMed Web of Science ®Google Scholar
• Nygaard B, Jensen EW, Kvetny J, et al. Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. Eur J Endocrinol. 2009;161(6):895–902.
   PubMed Web of Science ®Google Scholar
• Clyde PW, Harari AE, Getka EJ, et al. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA. 2003;290(22):2952–2958.
   PubMed Web of Science ®Google Scholar
• Sawka AM, Gerstein HC, Marriott MJ, et al. Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab. 2003;88(10):4551–4555.
   PubMed Web of Science ®Google Scholar
• Bunevicius R, Kazanavicius G, Zalinkevicius R, et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340(6):424–429.
   PubMed Web of Science ®Google Scholar
• Bunevicius R, Prange AJ. Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism. Int J Neuropsychopharmacol. 2000;3(2):167–174.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, et al. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med. 2005;142(6):412–424.
   PubMed Web of Science ®Google Scholar
• Kaminski J, Miasaki FY, Paz-Filho G, et al. Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study. Arch Endocrinol Metab. 2016;60(6):562–572.
   PubMed Web of Science ®Google Scholar
• Rodriguez T, Lavis VR, Meininger JC, et al. Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocr Pract. 2005;11(4):223–233.
   PubMedGoogle Scholar
• Siegmund W, Spieker K, Weike AI, et al. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14: 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol. 2004;60(6):750–757.
   PubMed Web of Science ®Google Scholar
• Bunevicius R, Jakuboniene N, Jurkevicius R, et al. Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease. Endocrine. 2002;18(2):129–133.
   PubMed Web of Science ®Google Scholar
• Krysiak R, Szkróbka W, Okopień B. Sexual function and depressive symptoms in young women with hypothyroidism receiving levothyroxine/liothyronine combination therapy: a pilot study. Curr Med Res Opin. 2018;34(9):1579–1586.
   PubMed Web of Science ®Google Scholar
• Fischman A, Domínguez JM. Combined therapy with levothyroxine and liothyronine for hypothyroidism. Medwave. 2018;18(8):e7376.
   PubMed Web of Science ®Google Scholar
• Millan-Alanis JM, Gonzalez-Gonzalez JG, Flores-Rodríguez A, et al. Benefits and harms of levothyroxine/liothyronine vs. levothyroxine monotherapy for adult patients with hypothyroidism: systematic review and meta-analysis. Thyroid. 2021. DOI:https://doi.org/10.1089/thy.2021.0270
   PubMed Web of Science ®Google Scholar
• Leese GP, Soto-Pedre E, Donnelly LA. Liothyronine use in a 17 year observational population-based study - the tears study. Clin Endocrinol. 2016;85(6):918–925.
   PubMed Web of Science ®Google Scholar
• Michaelsson LF, la Cour JL, Medici BB, et al. Levothyroxine/liothyronine combination therapy and quality of life: is it all about weight loss? Eur Thyroid J. 2018;7(5):243–250.
   PubMed Web of Science ®Google Scholar
• Medici BB, la Cour JL, Michaelsson LF, et al. Neither baseline nor changes in serum triiodothyronine during levothyroxine/liothyronine combination therapy predict a positive response to this treatment modality in hypothyroid patients with persistent symptoms. Eur Thyroid J. 2017;6(2):89–93.
   PubMed Web of Science ®Google Scholar
• Saravanan P, Visser TJ, Dayan CM. Psychological well-being correlates with free thyroxine but not free 3,5,3'-triiodothyronine levels in patients on thyroid hormone replacement. J Clin Endocrinol Metab. 2006;91(9):3389–3393.
   PubMed Web of Science ®Google Scholar
• Solter D, Solter M. Benefit of combined triiodothyronine (LT(3)) and thyroxine (LT(4)) treatment in athyreotic patients unresponsive to LT(4) alone. Exp Clin Endocrinol Diabetes. 2012;120(02):121–123.
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Tefera E, Shara N. Physician choice of hypothyroidism therapy: influence of patient characteristics. Thyroid. 2018;28(11):1416–1424.
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Tefera E, Shara N. Prescribing therapy for hypothyroidism: influence of physician characteristics. Thyroid. 2019;29(1):44–52.
   PubMed Web of Science ®Google Scholar
• Toloza FJK, Espinoza Suarez NR, El Kawkgi O, et al. Patient experiences and perceptions associated with the use of desiccated thyroid extract. Medicina. 2020;56:161.
   PubMed Web of Science ®Google Scholar
• Haskins C. Bogus hypothyroid cures are rampant across social media. Buzzfeed article [cited 2021 Jul]. Available from: https://www.buzzfeednews.com/article/carolinehaskins1/sea-moss-does-not-cure-thyroid-disease-but-people-sell-it.
   Google Scholar
• Michaelsson LF, Medici BB, la Cour JL, et al. Treating hypothyroidism with thyroxine/triiodothyronine combination therapy in Denmark: following guidelines or following trends? Eur Thyroid J. 2015;4(3):174–180.
   PubMed Web of Science ®Google Scholar
• Hennemann G, Docter R, Visser TJ, et al. Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid. 2004;14(4):271–275.
   PubMed Web of Science ®Google Scholar
• Jonklaas J. Risks and safety of combination therapy for hypothyroidism. Expert Rev Clin Pharmacol. 2016;9(8):1057–1067.
   PubMed Web of Science ®Google Scholar
• Van Tassell B, Wohlford GF, 4th, Linderman JD, et al. Pharmacokinetics of L-triiodothyronine in patients undergoing thyroid hormone therapy withdrawal. Thyroid. 2019;29(10):1371–1379.
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Burman KD, Wang H, et al. Single-dose T3 administration: kinetics and effects on biochemical and physiological parameters. Ther Drug Monit. 2015;37(1):110–118.
   PubMed Web of Science ®Google Scholar
• Midgley JEM, Toft AD, Larisch R, et al. Time for a reassessment of the treatment of hypothyroidism. BMC Endocr Disord. 2019;19(1):37.
   PubMed Web of Science ®Google Scholar
• Hoermann R, Midgley JEM, Larisch R, et al. Lessons from randomised clinical trials for triiodothyronine treatment of hypothyroidism: have they achieved their objectives? J Thyroid Res. 2018;2018:3239197.
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Bianco AC, Cappola AR, et al. Evidence-based use of levothyroxine/liothyronine combinations in treating hypothyroidism: a consensus document. Eur Thyroid J. 2021;10(1):10–38.
   PubMed Web of Science ®Google Scholar
• DiStefano J, 3rd, Jonklaas J. Predicting optimal combination lt4 + lt3 therapy for hypothyroidism based on residual thyroid function. Front Endocrinol. 2019;10:746.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE guideline [NG145]; 2019 [cited 2021 Jul]. Available from: https://www.nice.org.uk/guidance/ng145/chapter/recommendations.
   Google Scholar
• Thienpont LM, Van Uytfanghe K, Beastall G, et al. Report of the IFCC working group for standardization of thyroid function tests; part 2: free thyroxine and free triiodothyronine. Clin Chem. 2010;56:91.
   Web of Science ®Google Scholar
• Midgley JE. Global FT4 immunoassay standardization. Response to: Kratzsch J et al. Global FT4 immunoassay standardization: an expert opinion review. Clin Chem Lab Med. 2021;59(6):e223–e224.
   PubMed Web of Science ®Google Scholar